Biotech Values

[dewophile]

There is a real unmet need here bc of the very high bleeding risk if you have someone who needs an antiplatelet agent for say TIA/stroke due to plaque who also needs to stay on a drug like eliquis for afib. Downstream effects would not just be to take share from Xa inhibitors, but also result in a mild negative for companies like BSX which sell devices like the watchman